These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 26100920)

  • 21. Biomarker Discovery in Parkinson's Disease: Present Challenges and Future Opportunities.
    Li S; Le W
    Neurosci Bull; 2017 Oct; 33(5):481-482. PubMed ID: 28936754
    [No Abstract]   [Full Text] [Related]  

  • 22. Human olfactory neurosphere-derived cells: A unified tool for neurological disease modelling and neurotherapeutic applications.
    Ansari S; Etekochay MO; Atanasov AG; Prasad VP; Kandimalla R; Mofatteh M; V P; Emran TB
    Int J Surg; 2024 Apr; ():. PubMed ID: 38652180
    [TBL] [Abstract][Full Text] [Related]  

  • 23. α-Synuclein and Lewy pathology in Parkinson's disease.
    Kalia LV; Kalia SK
    Curr Opin Neurol; 2015 Aug; 28(4):375-81. PubMed ID: 26110807
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low levels of astroglial markers in Parkinson's disease: relationship to α-synuclein accumulation.
    Tong J; Ang LC; Williams B; Furukawa Y; Fitzmaurice P; Guttman M; Boileau I; Hornykiewicz O; Kish SJ
    Neurobiol Dis; 2015 Oct; 82():243-253. PubMed ID: 26102022
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distinctive distribution of phospho-alpha-synuclein in dermal nerves in multiple system atrophy.
    Doppler K; Weis J; Karl K; Ebert S; Ebentheuer J; Trenkwalder C; Klebe S; Volkmann J; Sommer C
    Mov Disord; 2015 Oct; 30(12):1688-92. PubMed ID: 26175301
    [TBL] [Abstract][Full Text] [Related]  

  • 26. α-Synuclein in Parkinson's disease: getting to the core of the matter.
    Hauser RA
    Lancet Neurol; 2015 Aug; 14(8):785-786. PubMed ID: 26116313
    [No Abstract]   [Full Text] [Related]  

  • 27. Parkinson disease and progressive supranuclear palsy: protein expression in skin.
    Rodríguez-Leyva I; Chi-Ahumada EG; Carrizales J; Rodríguez-Violante M; Velázquez-Osuna S; Medina-Mier V; Martel-Gallegos MG; Zarazúa S; Enríquez-Macías L; Castro A; Calderón-Garcidueñas AL; Jiménez-Capdeville ME
    Ann Clin Transl Neurol; 2016 Mar; 3(3):191-9. PubMed ID: 27042679
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alpha-synuclein immunoreactivity patterns in the enteric nervous system.
    Aldecoa I; Navarro-Otano J; Stefanova N; Sprenger FS; Seppi K; Poewe W; Cuatrecasas M; Valldeoriola F; Gelpi E; Tolosa E
    Neurosci Lett; 2015 Aug; 602():145-9. PubMed ID: 26163460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Imaging pathological tau in atypical parkinsonian disorders.
    Coakeley S; Strafella AP
    Curr Opin Neurol; 2015 Aug; 28(4):447-52. PubMed ID: 26110795
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glucocerebrosidase deficiency and mitochondrial impairment in experimental Parkinson disease.
    Noelker C; Lu L; Höllerhage M; Vulinovic F; Sturn A; Roscher R; Höglinger GU; Hirsch EC; Oertel WH; Alvarez-Fischer D; Andreas H
    J Neurol Sci; 2015 Sep; 356(1-2):129-36. PubMed ID: 26104567
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Skin biopsies in the differential diagnosis of parkinsonism: are we ready for simplified protocols?
    Doppler K; Volkmann J; Sommer C
    Brain; 2016 Jan; 139(Pt 1):e5. PubMed ID: 26351270
    [No Abstract]   [Full Text] [Related]  

  • 32. α-Synuclein in Extracellular Vesicles: Functional Implications and Diagnostic Opportunities.
    Lööv C; Scherzer CR; Hyman BT; Breakefield XO; Ingelsson M
    Cell Mol Neurobiol; 2016 Apr; 36(3):437-48. PubMed ID: 26993503
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lysosomal Dysfunction and α-Synuclein Aggregation in Parkinson's Disease: Diagnostic Links.
    Moors T; Paciotti S; Chiasserini D; Calabresi P; Parnetti L; Beccari T; van de Berg WD
    Mov Disord; 2016 Jun; 31(6):791-801. PubMed ID: 26923732
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peripheral Synucleinopathy in Early Parkinson's Disease: Submandibular Gland Needle Biopsy Findings.
    Adler CH; Dugger BN; Hentz JG; Hinni ML; Lott DG; Driver-Dunckley E; Mehta S; Serrano G; Sue LI; Duffy A; Intorcia A; Filon J; Pullen J; Walker DG; Beach TG
    Mov Disord; 2016 Feb; 31(2):250-6. PubMed ID: 26799362
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson's disease.
    Majbour NK; Vaikath NN; van Dijk KD; Ardah MT; Varghese S; Vesterager LB; Montezinho LP; Poole S; Safieh-Garabedian B; Tokuda T; Teunissen CE; Berendse HW; van de Berg WD; El-Agnaf OM
    Mol Neurodegener; 2016 Jan; 11():7. PubMed ID: 26782965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of Submandibular Gland Synucleinopathy in Parkinson's Disease, Dementia with Lewy Bodies and other Lewy Body Disorders.
    Beach TG; Adler CH; Serrano G; Sue LI; Walker DG; Dugger BN; Shill HA; Driver-Dunckley E; Caviness JN; Intorcia A; Filon J; Scott S; Garcia A; Hoffman B; Belden CM; Davis KJ; Sabbagh MN;
    J Parkinsons Dis; 2016; 6(1):153-63. PubMed ID: 26756744
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Skin nerve misfolded α-synuclein in pure autonomic failure and Parkinson disease.
    Donadio V; Incensi A; Piccinini C; Cortelli P; Giannoccaro MP; Baruzzi A; Liguori R
    Ann Neurol; 2016 Feb; 79(2):306-16. PubMed ID: 26606657
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pioglitazone in early Parkinson's disease: a phase 2, multicentre, double-blind, randomised trial.
    NINDS Exploratory Trials in Parkinson Disease (NET-PD) FS-ZONE Investigators
    Lancet Neurol; 2015 Aug; 14(8):795-803. PubMed ID: 26116315
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting α-synuclein as a therapeutic strategy for Parkinson's disease.
    Lawand NB; Saadé NE; El-Agnaf OM; Safieh-Garabedian B
    Expert Opin Ther Targets; 2015; 19(10):1351-60. PubMed ID: 26135549
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fibril growth and seeding capacity play key roles in α-synuclein-mediated apoptotic cell death.
    Mahul-Mellier AL; Vercruysse F; Maco B; Ait-Bouziad N; De Roo M; Muller D; Lashuel HA
    Cell Death Differ; 2015 Dec; 22(12):2107-22. PubMed ID: 26138444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.